BOCCACCIO CARLA,COMOGLIO PAOLO MARIA,PETRONZELLI FIORELLA,DE SANTIS RITA
申请号：
IN270/KOL/2012
公开号：
IN2012KO00270A
申请日:
2012.03.13
申请国别(地区):
IN
年份:
2016
代理人:
摘要：
Met inhibitor and/or nucleotide sequence encoding a Met inhibitor for use in the treatment of patients suffering from a cancer for reducing and/or abrogating patients’ resistance to radiotherapy, wherein the Met inhibitor is selected among: i) an anti-Met monoclonal antibody, ii) a genetically engineered antibody containing the complementarity determining regions (CDRs) of the anti- Met monoclonal antibody, and iii) a fragment of (i) or (ii) containing the complementarity determining regions (CDRs) of the anti- Met monoclonal antibody, or combinations thereof.
